Barrie J. Carter

Barrie J. Carter

Director/Board Member at
American Society of Gene Therapy
81 year
Health Technology
Consumer Services
Government

Profile

Barrie J.
Carter
is currently the Director at the American Society of Gene Therapy and a Member-Advisory Committee at the University of Washington.
Previously, he held positions as the Director at Opus Bio, Inc., Chief Scientific Officer & Executive VP at AmpliPhi Biosciences Corp.
from 1992 to 2008, Vice President-Vector Biology at BioMarin Pharmaceutical, Inc. from 2013 to 2018, Principal at the National Institutes of Health in 1992, Principal at the National Institute of Diabetes & Digestive & Kidney Diseases from 1982 to 1992, and was a Member-Advisory Board at Keystone Symposia.
Dr. Carter obtained his undergraduate degree from the University of Otago in 1996 and his doctorate degree from the same university in 1969.

Barrie J. Carter active positions

CompaniesPositionStart
American Society of Gene Therapy
Director/Board Member -
Corporate Officer/Principal 1999-12-31

Former positions of Barrie J. Carter

CompaniesPositionEnd
BIOMARIN PHARMACEUTICAL INC. Corporate Officer/Principal 2018-11-30
Chief Tech/Sci/R&D Officer 2008-11-05
Corporate Officer/Principal 1991-12-31
Corporate Officer/Principal 1991-12-31
Director/Board Member 2011-10-30
See the detail of Barrie J. Carter's experience

Training of Barrie J. Carter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Consumer Services

Consumer Services

Government

Government

Commercial Services

Commercial Services

American Society of Gene Therapy

  1. Stock Market
  2. Insiders
  3. Barrie J. Carter